Skip to main content

Please join us for the Leadiant Meet the Clinicians Reception during the IDF 2019 National Conference. Leadiant will provide a brief corporate overview and an introduction to the new enzyme replacement therapy (ERT) for adenosine deaminase severe combined immune deficiency (ADA-SCID).

Clinicians will have the opportunity to:
Meet with other clinicians to engage in discussion on the following:

  • Introduction of a new enzyme replacement therapy (ERT) for ADA-SCID
  • Transition from previous treatment to new ERT treatment
  • Evolving treatment paradigm
  • Insights and feedback from patients on their experience through the transition
  • Educational needs and ongoing programs and materials

Registration and Details Below

When:
Wednesday, June 19
7:00 – 9:00 p.m. ET
Where:
The Tasting Room Wine Bar
137 Waterfront St., Oxon Hill, MD 20745

Beverages and appetizers will be available during the reception.

For more information, please contact Lesli King, Director of Marketing, at lesli.king@leadiant.com or 301-670-5450.

To learn more about Leadiant, please visit www.leadiant.com.